# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001558370-23-014403
Filing Date
2023-08-10
Accepted
2023-08-10 07:36:21
Documents
40
Period of Report
2023-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | apre-20230810x8k.htm iXBRL | 8-K | 41592
2 | EX-99.1 | apre-20230810xex99d1.htm | EX-99.1 | 129092
3 | EX-99.2 | apre-20230810xex99d2.htm | EX-99.2 | 39258
4 | GRAPHIC | apre-20230810xex99d2g001.jpg | GRAPHIC | 77393
5 | GRAPHIC | apre-20230810xex99d2g002.jpg | GRAPHIC | 393069
6 | GRAPHIC | apre-20230810xex99d2g003.jpg | GRAPHIC | 201537
7 | GRAPHIC | apre-20230810xex99d2g004.jpg | GRAPHIC | 150474
8 | GRAPHIC | apre-20230810xex99d2g005.jpg | GRAPHIC | 186543
9 | GRAPHIC | apre-20230810xex99d2g006.jpg | GRAPHIC | 67463
10 | GRAPHIC | apre-20230810xex99d2g007.jpg | GRAPHIC | 157600
11 | GRAPHIC | apre-20230810xex99d2g008.jpg | GRAPHIC | 148153
12 | GRAPHIC | apre-20230810xex99d2g009.jpg | GRAPHIC | 161493
13 | GRAPHIC | apre-20230810xex99d2g010.jpg | GRAPHIC | 151509
14 | GRAPHIC | apre-20230810xex99d2g011.jpg | GRAPHIC | 173057
15 | GRAPHIC | apre-20230810xex99d2g012.jpg | GRAPHIC | 177217
16 | GRAPHIC | apre-20230810xex99d2g013.jpg | GRAPHIC | 196302
17 | GRAPHIC | apre-20230810xex99d2g014.jpg | GRAPHIC | 204727
18 | GRAPHIC | apre-20230810xex99d2g015.jpg | GRAPHIC | 68322
19 | GRAPHIC | apre-20230810xex99d2g016.jpg | GRAPHIC | 113979
20 | GRAPHIC | apre-20230810xex99d2g017.jpg | GRAPHIC | 136774
21 | GRAPHIC | apre-20230810xex99d2g018.jpg | GRAPHIC | 119236
22 | GRAPHIC | apre-20230810xex99d2g019.jpg | GRAPHIC | 66041
23 | GRAPHIC | apre-20230810xex99d2g020.jpg | GRAPHIC | 212705
24 | GRAPHIC | apre-20230810xex99d2g021.jpg | GRAPHIC | 74313
25 | GRAPHIC | apre-20230810xex99d2g022.jpg | GRAPHIC | 142010
26 | GRAPHIC | apre-20230810xex99d2g023.jpg | GRAPHIC | 176932
27 | GRAPHIC | apre-20230810xex99d2g024.jpg | GRAPHIC | 125804
28 | GRAPHIC | apre-20230810xex99d2g025.jpg | GRAPHIC | 77393
| Complete submission text file | 0001558370-23-014403.txt |  | 5543550

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
29 | EX-101.SCH | apre-20230810.xsd | EX-101.SCH | 3900
30 | EX-101.DEF | apre-20230810_def.xml | EX-101.DEF | 2845
31 | EX-101.LAB | apre-20230810_lab.xml | EX-101.LAB | 17246
32 | EX-101.PRE | apre-20230810_pre.xml | EX-101.PRE | 11356
34 | EXTRACTED XBRL INSTANCE DOCUMENT | apre-20230810x8k_htm.xml | XML | 4859

Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 267-370-5219
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 231157199
SIC: 2834 Pharmaceutical Preparations